BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12-to-15-year-olds in Europe from June.
The German firm’s CEO Ugur Sahin told Der Spiegel weekly that it was “in the final stretches” of preparing its submission for European regulatory approval. The evaluation of the trial data “takes four to six weeks on average”, he added.
© 2021 AFP
BioNTech eyes COVID vaccine for 12-15 year olds from June in EU (2021, April 29)
retrieved 29 April 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.